AdapTive Personalized Dietitian coacHing, Messaging and pRoduce prescrIption to improVE Healthy Dietary Behaviors
THRIVE
THRIVE: AdapTive Personalized Dietitian coacHing, Messaging and pRoduce prescrIption to improVE Healthy Dietary Behaviors
2 other identifiers
interventional
80
1 country
1
Brief Summary
THRIVE intervention is a 2-arm randomized pilot trial testing the feasibility and preliminary efficacy of producing prescriptions, tailored dietitian counseling with adaptive messages, and linkages to social resources among 80 Black adults with hypertension.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hypertension
Started Jun 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 5, 2024
CompletedFirst Posted
Study publicly available on registry
February 14, 2024
CompletedStudy Start
First participant enrolled
June 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2025
CompletedNovember 5, 2025
November 1, 2025
1.4 years
February 5, 2024
November 4, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
DASH Adherence as assessed by the Automated Self-Administered 24-hour Dietary Assessment Tool (ASA24)
Adherence will be assessed by the Automated Self-Administered 24-hour Dietary Assessment Tool (ASA24). The scores range from 0 to 100, with higher scores reflecting greater adherence.
0, 12 weeks and 24 weeks
Secondary Outcomes (9)
Recruitment rate
0, 12 weeks, 24 weeks
Cost of the intervention
0, 12 weeks, 24 weeks
Participant Accrual
0, 12 weeks and 24 weeks
Number of referrals to health and social need resources
0, 12 weeks and 24 weeks
Systolic Blood pressure
0, 12 and 24 weeks
- +4 more secondary outcomes
Study Arms (2)
THRIVE Intervention Arm
EXPERIMENTALThe THRIVE intervention arm will receive produce prescription, personalized dietitian coaching, adaptive bi-directional messaging; and linkages to social services.
Comparator Arm
ACTIVE COMPARATORThe comparator arm will receive standard produce bags; and linkages to social services.
Interventions
THRIVE Intervention includes: 1. Weekly Pulse Surveys 2. Adaptive culturally tailored messages 3. Personalized Dietitian Coaching 4. Produce Prescription "FARMacy" Mobile Market 5. Linkages to Social Services
The Active Comparator arm will receive standard produce bags through our food is medicine partner, and will receive the linkages to needed social and health resources intervention components.
Eligibility Criteria
You may qualify if:
- years or older
- Self-identify as Black/African American
- Have diagnosed hypertension stages 1 (130-139/80-89 mm Hg) OR 2 (\>140/90 mm Hg), determined via self-report and/or Electronic Medical Records (EMR)
- Live in census tracts identified by Montgomery County Department of Planning as HFPA:
- Healthy Food Availability Index score is low (0-9.5),
- Median household income ≤185% of Federal Poverty Level
- \>30% households have no vehicle, Distance to supermarket \>1/4 mile.
- Participants must have refrigeration, food appliances (microwave, stove),
- Cell phone to receive messages
You may not qualify if:
- Age \<18 years
- Type 1 or Type 2 Diabetes defined as a hemoglobin A1c ≥6.5% or diabetes treatment
- Diagnosis of end-stage renal disease (ESRD)
- Condition which interferes with outcome measurement (e.g., dialysis)
- Serious medical condition which either limits life expectancy or requires active management (e.g. cancer)
- Significant food allergies, preferences, intolerances, or dietary requirements that would interfere with diet adherence
- Patients with cognitive impairment or other condition preventing their participation in the intervention
- Current participation in a care management program related to health conditions (e.g., weight reduction, smoking cessation)
- Current participation in another clinical trial that could interfere with the study protocol
- Those planning to move out of the geographic area in 12 months
- Unwillingness to provide informed consent
- Other conditions or situations at the discretion of the Investigative team
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Johns Hopkins Universitylead
- American Heart Associationcollaborator
Study Sites (1)
Johns Hopkins University
Baltimore, Maryland, 21205, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Oluwabunmi Ogungbe, PhD, MPH, RN
JHU School Of Nursing
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcomes assessors and data analysts will be masked to treatment allocation.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 5, 2024
First Posted
February 14, 2024
Study Start
June 10, 2024
Primary Completion
October 20, 2025
Study Completion
October 31, 2025
Last Updated
November 5, 2025
Record last verified: 2025-11